• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Fortis Share Price

    Fortis Healthcare Share PriceFortis Healthcare

    Large Cap 8.9k Result
    ₹382.05
    -3.5 (-0.91%)
    • Advice
    • Hold
    As on 10 December, 2023 | 12:55 BSE: 532843 NSE: FORTISISIN: INE061F01013

    Fortis Healthcare Performance

    Day Range

    • Low 380.00
    • High 384.50
    ₹ 382.05

    52 Week Range

    • Low 245.50
    • High 390.00
    ₹ 382.05
    • Open Price383.00
    • Previous Close385.55
    • Volume1682641

    Start SIP in Fortis Healthcare

    Start SIP

    Fortis Healthcare Share Price

    • Over 1 Month 12.29%
    • Over 3 Month 12.6%
    • Over 6 Month 36.06%
    • Over 1 Year 35.22%

    Fortis Healthcare Key Statistics

    P/E Ratio 52.7
    PEG Ratio 7.4
    Market Cap Cr 28,843
    Price to Book Ratio 3.6
    EPS 0.7
    Dividend 0.3
    Relative Strength Index 65.07
    Money Flow Index 68.1
    MACD Signal 11.17
    Average True Range 9.89

    Fortis Healthcare Investment Rating

    • Master Rating:

    • Fortis Healthcare (Nse) has an operating revenue of Rs. 6,629.94 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 13% is healthy, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 8%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 9% and 23% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 9% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 25 which is a POOR score indicating inconsistency in earnings, a RS Rating of 61 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 72 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Fortis Healthcare Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 294289277262266247210
    Operating Expenses Qtr Cr 255254250226228215191
    Operating Profit Qtr Cr 40352836383219
    Depreciation Qtr Cr 25252929292828
    Interest Qtr Cr 21232525282833
    Tax Qtr Cr 851443-2
    Net Profit Qtr Cr 951321982-8-24
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 1,203997
    Operating Expenses Annual Cr 920747
    Operating Profit Annual in Cr 133115
    Depreciation Cr 116113
    Interest Annual Cr 106130
    Tax Annual Cr 134
    Net Profit Annual Cr 96-13
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 19876
    Cash from Investing Activity Annual Cr 205238
    Cash from Financing Annual Activity Cr -395-320
    Net Cash Flow Annual Cr 8-6
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 8,9648,869
    Fixed Assets Annual Cr 495777
    Total Non Current Assets Annual Cr 9,67910,021
    Total Current Assets Annual Cr 690406
    Total Assets Annual Cr 10,36910,426
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 119117
    ROE Annual % 10
    ROCE Annual % 21
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2729
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 1,7701,6571,6431,5601,6071,4881,378
    Operating Expenses Qtr Cr 1,4401,3851,3721,2831,3041,2371,157
    Operating Profit Qtr Cr 330272271276303251221
    Depreciation Qtr Cr 84798283777477
    Interest Qtr Cr 32313233333130
    Tax Qtr Cr 49474544504239
    Net Profit Qtr Cr 17411213313020412268
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 6,3595,745
    Operating Expenses Annual Cr 5,1964,649
    Operating Profit Annual in Cr 1,1011,069
    Depreciation Cr 316301
    Interest Annual Cr 129147
    Tax Annual Cr 181198
    Net Profit Annual Cr 589555
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 822865
    Cash from Investing Activity Annual Cr -374-514
    Cash from Financing Annual Activity Cr -471-517
    Net Cash Flow Annual Cr -23-166
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 7,2426,178
    Fixed Assets Annual Cr 5,5135,486
    Total Non Current Assets Annual Cr 11,02710,751
    Total Current Assets Annual Cr 1,4061,133
    Total Assets Annual Cr 12,43411,885
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 10793
    ROE Annual % 89
    ROCE Annual % 87
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1819
    Invest in Fortis Healthcare

    Fortis Healthcare Technicals

    EMA & SMA

    Current Price
    ₹382.05
    -3.5 (-0.91%)
    pointer
    • Bullish Moving Average
    • ___
    • 14
    • Bearish Moving Average
    • ___
    • 2
    • 20 Day
    • ₹371.56
    • 50 Day
    • ₹355.01
    • 100 Day
    • ₹339.88
    • 200 Day
    • ₹320.62
    • 20 Day
    • ₹372.18
    • 50 Day
    • ₹348.86
    • 100 Day
    • ₹339.98
    • 200 Day
    • ₹309.75

    Fortis Healthcare Resistance and Support

    PIVOT
    ₹382.19
    Resistance
    First Resistance 384.37
    Second Resistance 386.68
    Third Resistance 388.87
    RSI 65.07
    MFI 68.10
    MACD Single Line 11.17
    MACD 11.56
    Support
    First Resistance 379.87
    Second Resistance 377.68
    Third Resistance 375.37

    Fortis Healthcare Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 1,704,149 131,406,929 77.11
    Week 1,635,673 116,966,962 71.51
    1 Month 2,035,004 125,559,776 61.7
    6 Month 1,752,328 119,981,866 68.47

    Fortis Healthcare Result Highlights

    Fortis Healthcare Synopsis

    NSE-Medical-Hospitals

    Fortis Healthcare is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 1052.93 Cr. and Equity Capital is Rs. 754.96 Cr. for the Year ended 31/03/2023. Fortis Healthcare Ltd. is a Public Limited Listed company incorporated on 28/02/1996 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L85110PB1996PLC045933 and registration number is 045933.
    Market Cap 28,843
    Sales 1,123
    Shares in Float 52.09
    No of funds 265
    Yield 0.26
    Book Value 3.22
    U/D Vol ratio 1.3
    LTDebt / Equity 3
    Alpha 0.11
    Beta 0.39

    Fortis Healthcare

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 31.17%31.17%31.17%31.17%
    Mutual Funds 22.5%18.49%17.38%17.5%
    Insurance Companies 2.8%2.39%2.07%1.64%
    Foreign Portfolio Investors 26.31%30.03%31.22%31.01%
    Financial Institutions/ Banks 1.19%1.2%1.19%1.19%
    Individual Investors 11.13%11.81%12.06%12.39%
    Others 4.9%4.91%4.91%5.1%

    Fortis Healthcare Management

    Name Designation
    Mr. Ravi Rajagopal Chairman & Ind.Director
    Dr. Ashutosh Raghuvanshi Managing Director & CEO
    Ms. Suvalaxmi Chakraborty Independent Director
    Mr. Indrajit Banerjee Independent Director
    Ms. Shailaja Chandra Independent Director
    Mr. Tomo Nagahiro Non Executive Director
    Mr. Dilip Kadambi Non Executive Director
    Mr. Heng Joo Joe Sim Non Executive Director
    Mr. Lim Tsin Lin Non Executive Director
    Mr. Mehmet Ali Aydinlar Non Executive Director
    Mr. Joerg Ayrle Non Executive Director

    Fortis Healthcare Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Fortis Healthcare Corporate Action

    Date Purpose Remarks
    2023-11-10 Quarterly Results
    2023-08-04 Quarterly Results
    2023-05-23 Audited Results & Final Dividend
    2023-02-10 Quarterly Results
    2022-11-11 Quarterly Results
    Date Purpose Remarks
    2023-07-20 FINAL Rs.1.00 per share(10%)Final Dividend

    Fortis Healthcare MF Shareholding

    Name Amount(cr)
    HDFC Mid-Cap Opportunities Fund Growth 47,846
    Mirae Asset Emerging Bluechip Fund Growth 28,104
    HDFC Small Cap Fund Growth 25,409
    Axis Midcap Fund Growth 21,962
    Nippon India Growth Fund - Growth 21,380

    Fortis Healthcare FAQs

    What is Share Price of Fortis Healthcare ?

    Fortis Healthcare share price is ₹382 As on 10 December, 2023 | 12:41

    What is the Market Cap of Fortis Healthcare ?

    The Market Cap of Fortis Healthcare is ₹28843.2 Cr As on 10 December, 2023 | 12:41

    What is the P/E ratio of Fortis Healthcare ?

    The P/E ratio of Fortis Healthcare is 52.7 As on 10 December, 2023 | 12:41

    What is the PB ratio of Fortis Healthcare ?

    The PB ratio of Fortis Healthcare is 3.6 As on 10 December, 2023 | 12:41

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.